Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 116–116 | Cite as

Eltrombopag

Mild thrombocytosis following an off label use: case report
Case report
  • 11 Downloads

Reference

  1. Dellacasa CM, et al. Eltrombopag for the treatment of refractory pure red cell aplasia (PRCA) after major ABO incompatible hematopoietic stem cell transplantation (HSCT). HemaSphere 2 (Suppl. 1): 1089 abstr. PB2474, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] -Italy

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations